Novartis Investigative Site

Irbid 22110

0 studies enrolling now · 7 studies all time

What they study most

Acute Heart Failure, Behcet Disease, Familial Hypercholesterolemia - Heterozygous, Heterozygous or Homozygous Familial Hypercholesterolemia, Persistent Asthma, Relapsing Forms of Multiple Sclerosis, Sickle Cell Disease (SCD)

Studies at this site

• Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies — Recruiting now
• Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients — Running, not enrolling
• Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia — Completed
• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed
• Global Non-interventional Heart Failure Disease Registry — Stopped early
• Phase III Study in Refractory Behcet's Disease — Completed
• Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol — Completed